Altered energy state reversibly controls smooth muscle contractile function in human saphenous vein during acute hypoxia-reoxygenation: Role of glycogen, AMP-activated protein kinase, and insulin-independent glucose uptake

Biochem Pharmacol. 2015 Sep 1;97(1):77-88. doi: 10.1016/j.bcp.2015.06.036. Epub 2015 Jul 23.

Abstract

Hypoxia is known to promote vasodilation of coronary vessels through several mediators including cardiac-derived adenosine and endothelium-derived prostanoids and nitric oxide. To date, the impact of endogenous glycogen depletion in vascular smooth muscle and the resultant alterations in cellular energy state (e.g., AMP-activated protein kinase, AMPK) on the contractile response to G protein-coupled receptor agonists (e.g., serotonin, 5-HT) has not yet been studied. In the present study, ex vivo exposure of endothelium-denuded human saphenous vein rings to hypoxic and glucose-deprived conditions during KCl-induced contractions for 30 min resulted in a marked depletion of endogenous glycogen by ∼80% (from ∼1.78 μmol/g under normoxia to ∼0.36 μmol/g under hypoxia). Importantly, glycogen-depleted HSV rings, which were maintained under hypoxia/reoxygenation and glucose-deprived conditions, exhibited significant increases in basal AMPK phosphorylation (∼6-fold ↑) and 5-HT-induced AMPK phosphorylation (∼19-fold ↑) with an accompanying suppression of 5-HT-induced maximal contractile response (∼68% ↓), compared with respective controls. Exposure of glycogen-depleted HSV rings to exogenous D-glucose, but not the inactive glucose analogs, prevented the exaggerated increase in 5-HT-induced AMPK phosphorylation and restored 5-HT-induced maximal contractile response. In addition, the ability of exogenous D-glucose to rescue cellular stress and impaired contractile function occurred through GLUT1-mediated but insulin/GLUT4-independent mechanisms. Together, the present findings from clinically-relevant human saphenous vein suggest that the loss of endogenous glycogen in vascular smooth muscle and the resultant accentuation of AMPK phosphorylation by GPCR agonists may constitute a yet another mechanism of metabolic vasodilation of coronary vessels in ischemic heart disease.

Keywords: AMPK; Glycogen; Hypoxia; Serotonin; Vascular smooth muscle.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • AMP-Activated Protein Kinases / metabolism*
  • Aged
  • Allostasis*
  • Animals
  • Aorta, Thoracic / metabolism
  • Biological Transport
  • Cell Hypoxia
  • Enzyme Activation
  • Female
  • Glucose / analogs & derivatives
  • Glucose / metabolism*
  • Glycogen / metabolism*
  • Glycogenolysis
  • Humans
  • In Vitro Techniques
  • Male
  • Middle Aged
  • Muscle, Smooth, Vascular / enzymology
  • Muscle, Smooth, Vascular / metabolism*
  • Myocardial Ischemia / enzymology
  • Myocardial Ischemia / metabolism*
  • Oxidative Stress
  • Phosphorylation
  • Protein Processing, Post-Translational
  • Rats, Wistar
  • Saphenous Vein / enzymology
  • Saphenous Vein / metabolism*
  • Vasoconstriction

Substances

  • Glycogen
  • AMP-Activated Protein Kinases
  • Glucose